Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.

× No keyword cloud information.

35 in total

Review 1. Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.

Authors: Shom Goel; Andus Hon-Kit Wong; Rakesh K Jain
Journal: Cold Spring Harb Perspect Med Date: 2012-03 Impact factor: 6.915

Authors: Sebastian Föllner; Michael Ibe; Jens Schreiber
Journal: Eur J Clin Pharmacol Date: 2012-05-30 Impact factor: 2.953

Authors: Kornelia E C Wirsching; Frank Haubner; Thomas S Kühnel
Journal: Eur Arch Otorhinolaryngol Date: 2017-01-09 Impact factor: 2.503

Authors: E Lücke; J Schreiber; M Zencker; R Braun-Dullaeus; J Herold
Journal: Internist (Berl) Date: 2016-06 Impact factor: 0.743

Authors: C Rohrmeier; T S Kühnel
Journal: HNO Date: 2012-11 Impact factor: 1.284

Authors: Y H Kim; M-J Kim; S-W Choe; D Sprecher; Y J Lee; S P Oh
Journal: J Thromb Haemost Date: 2017-05-03 Impact factor: 5.824

Authors: Rosemary J Akhurst
Journal: Nat Med Date: 2010-04 Impact factor: 53.440

Authors: C Rohrmeier; H G Sachs; T S Kuehnel
Journal: Eur Arch Otorhinolaryngol Date: 2011-07-31 Impact factor: 2.503

Authors: Simon Kaja; Jill D Hilgenberg; Eric Everett; Scott E Olitsky; Jim Gossage; Peter Koulen
Journal: Hum Antibodies Date: 2011

Authors: Rupal S Bhatt; Michael B Atkins
Journal: Clin Cancer Res Date: 2014-04-08 Impact factor: 12.531